Funding

Proceeds will support clinical study of the BalancedBack Total Joint Replacement spinal fusion alternative in the U.S.

Proceeds will support clinical development of Osteal's lead candidate, VT-X7, for periprosthetic joint infection.

The company has launched a U.S. subsidiary to commercialize the V-STRUT vertebral implant.

Proceeds will accelerate the commercial deployment of Neo Medical's AI-driven ADVISE augmented reality platform for spinal surgery.

Funds will support development and commercialization of minimally invasive spinal diagnostic and therapeutic solutions.

Bactiguard and Zimmer Biomet have co-developed implants with the Bactiguard technology, to prevent post-operative infections.

FibroFix technology is a tissue scaffold based on fibroin, a tissue regenerative protein extracted from silk fibers.

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process.

The company has developed a novel bone cement for the treatment of spinal vertebrae fractures and other orthopedic procedures.

Proceeds will support regulatory and clinical activities for the VCFix vertebral body augmentation system.